Pfizer BioNTech COVID-19 Vaccine Approval in Singapore - New LP.8.1 Variant Protection

Описание: Pfizer, BioNTech, COVID-19 vaccine, Singapore approval, LP.8.1 adapted vaccine
Learn about the latest COVID-19 vaccine update from Pfizer and BioNTech. The Health Sciences Authority in Singapore has approved the LP.8.1-adapted monovalent COVID-19 vaccine, making it the first Southeast Asian country to get this updated shot.
This vaccine targets the LP.8.1 sublineage based on recommendations from the FDA, EMA, and WHO. It's designed for fall 2025 use and offers protection against emerging SARS-CoV-2 variants.
Key highlights include:
Available in October 2025 at selected polyclinics and GP clinics.
Suitable for individuals 6 months and older.
Free under Singapore's National Vaccination Programme for eligible residents.
Pfizer's Deborah Seifert emphasizes the commitment to public health through innovation. Dr. Aziz Noordin from Tampines Family Medicine Clinic highlights the importance for high-risk groups like seniors.
Stay informed on the latest COVID-19 developments and protect your community with timely vaccinations.